These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 35449866)

  • 1. Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma.
    Wang H; Fu Y; Da BB; Xiong G
    J Healthc Eng; 2022; 2022():8256314. PubMed ID: 35449866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
    Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
    Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Genes Associated with Tumor-Infiltrating Non-regulatory CD4- and CD8-Positive T Cells in Microenvironment of Hepatocellular Carcinoma.
    Zhao Z; Wang C; Chu P; Lu X
    Biochem Genet; 2022 Oct; 60(5):1762-1780. PubMed ID: 35092558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel CD8
    Li X; Qu X; Li S; Lin K; Yao N; Wang N; Shi Y
    Cancer Control; 2024; 31():10732748241270583. PubMed ID: 39152700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
    Zhang K; Xie K; Huo X; Liu L; Liu J; Zhang C; Wang J
    Biomed Res Int; 2022; 2022():9168441. PubMed ID: 36246969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
    Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma.
    Chen XQ; Ma J; Xu D; Xiang ZL
    BMC Bioinformatics; 2023 Jun; 24(1):270. PubMed ID: 37386390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma.
    Xiao J; Liu T; Liu Z; Xiao C; Du J; Zuo S; Li H; Gu H
    Cells; 2022 Jul; 11(15):. PubMed ID: 35892599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma.
    Chen C; Chen Z; Zhou Z; Ye H; Xiong S; Hu W; Xu Z; Ge C; Zhao C; Yu D; Shen J
    Front Immunol; 2024; 15():1424752. PubMed ID: 38919610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
    Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
    Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holliday Cross-Recognition Protein
    Luo D; Liao S; Liu Y; Lin Y; Li Y; Liao X
    Pathol Oncol Res; 2022; 28():1610506. PubMed ID: 35783358
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
    Hou Y; Zhang G
    Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma.
    Ding H; Hu H; Tian F; Liang H
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33656546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep dissection of stemness-related hierarchies in hepatocellular carcinoma.
    Liang R; Hong W; Zhang Y; Ma D; Li J; Shi Y; Luo Q; Du S; Song G
    J Transl Med; 2023 Sep; 21(1):631. PubMed ID: 37717019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-tumor heterogeneity and prognostic risk signature for hepatocellular carcinoma based on single-cell analysis.
    Liu C; Pu M; Ma Y; Wang C; Kong L; Zhang S; Zhao X; Lian X
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1741-1751. PubMed ID: 36330895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD8
    Li J; Chen H; Bai L; Tang H
    BMC Cancer; 2024 Jan; 24(1):53. PubMed ID: 38200408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
    Chen J; Chen X; Li T; Wang L; Lin G
    Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.